BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 32880751)

  • 1. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
    Ma H; Shen L; Yang H; Gong H; Du X; Li J
    IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF1α-mediated transactivation of WTAP promotes AML cell proliferation via m
    Shao YL; Li YQ; Li MY; Wang LL; Zhou HS; Liu DH; Yu L; Lin J; Gao XN
    Leukemia; 2023 Jun; 37(6):1254-1267. PubMed ID: 37087529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N
    Cheng Y; Xie W; Pickering BF; Chu KL; Savino AM; Yang X; Luo H; Nguyen DT; Mo S; Barin E; Velleca A; Rohwetter TM; Patel DJ; Jaffrey SR; Kharas MG
    Cancer Cell; 2021 Jul; 39(7):958-972.e8. PubMed ID: 34048709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.
    Han X; Liu J; Cheng G; Cui S
    Cancer Control; 2020; 27(1):1073274820960460. PubMed ID: 32951457
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
    Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m
    Wang J; Zhang J; Ma Y; Zeng Y; Lu C; Yang F; Jiang N; Zhang X; Wang Y; Xu Y; Hou H; Jiang S; Zhuang S
    Aging (Albany NY); 2021 Mar; 13(8):11135-11149. PubMed ID: 33819187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumour 1-associating protein inhibits endothelial cell angiogenesis by m6A-dependent epigenetic silencing of desmoplakin in brain arteriovenous malformation.
    Wang LJ; Xue Y; Li H; Huo R; Yan Z; Wang J; Xu H; Wang J; Cao Y; Zhao JZ
    J Cell Mol Med; 2020 May; 24(9):4981-4991. PubMed ID: 32281240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.
    Li H; Su Q; Li B; Lan L; Wang C; Li W; Wang G; Chen W; He Y; Zhang C
    J Cell Mol Med; 2020 Apr; 24(8):4452-4465. PubMed ID: 32176425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilms' tumor 1-associating protein contributes to psoriasis by promoting keratinocytes proliferation via regulating cyclinA2 and CDK2.
    Kong Y; Wu R; Zhang S; Zhao M; Wu H; Lu Q; Fu S; Su Y
    Int Immunopharmacol; 2020 Nov; 88():106918. PubMed ID: 32866786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Li G; Deng L; Huang N; Cui Z; Wu Q; Ma J; Pan Q; Sun F
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.
    Fan Y; Li X; Sun H; Gao Z; Zhu Z; Yuan K
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGR2-mediated regulation of m
    Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
    Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WTAP-mediated m
    Li ZX; Zheng ZQ; Yang PY; Lin L; Zhou GQ; Lv JW; Zhang LL; Chen F; Li YQ; Wu CF; Li F; Ma J; Liu N; Sun Y
    Cell Death Differ; 2022 Jun; 29(6):1137-1151. PubMed ID: 34999731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTORC1 stimulates cell growth through SAM synthesis and m
    Villa E; Sahu U; O'Hara BP; Ali ES; Helmin KA; Asara JM; Gao P; Singer BD; Ben-Sahra I
    Mol Cell; 2021 May; 81(10):2076-2093.e9. PubMed ID: 33756106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N
    Yu H; Zhao K; Zeng H; Li Z; Chen K; Zhang Z; Li E; Wu Z
    Biomed Pharmacother; 2021 Jan; 133():111075. PubMed ID: 33378974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.
    Gil-Kulik P; Dudzińska E; Radzikowska-Büchner E; Wawer J; Jojczuk M; Nogalski A; Wawer GA; Feldo M; Kocki W; Cioch M; Bogucka-Kocka A; Rahnama M; Kocki J
    BMC Cancer; 2020 May; 20(1):435. PubMed ID: 32423430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi prodrugs decrease elevated mRNA levels of Polo-like kinase 1 in ex vivo cultured primary cells from pediatric acute myeloid leukemia patients.
    Kolosenko I; Goroshchuk O; Vidarsdottir L; Björklund AC; Dowdy SF; Palm-Apergi C
    FASEB J; 2021 May; 35(5):e21476. PubMed ID: 33788972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.